NeuroVive Appoints Chief Operating Officer
NeuroVive's pipeline also includes a cyclophilin inhibitor for stroke and drug candidates that act on mitochondria to address energy regulation disorders.
NeuroVive´s shares are listed on the Swedish trading platform AktieTorget ( http://www.aktietorget.se). The AktieTorget market is focused on emerging, entrepreneurial businesses through an electronic trading system supplied by the OMX Nordic stock exchange in Stockholm, Sweden.
Media and investor relations contacts
NeuroVive Pharmaceutical: Mikael Bronnegard Email: email@example.com Phone No: +46 (0) 70 299 62 64Citigate Dewe Rogerson: Nina Enegren / David Dible Email: firstname.lastname@example.org Phone No: +44 207 282 1050 SOURCE NeuroVive
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts